Skip to content

US · IMCC · DRUG MANUFACTURERS - SPECIALTY & GENERIC

IM Cannabis Corp. (IMCC) intrinsic value and stock valuation

$0.50as of 2026-11-21 · Mkt cap 384.76K

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

IM Cannabis Corp. DCF and intrinsic value

InvestorsCraft values IMCC with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from IMCC’s statements →

IM Cannabis Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Drug Manufacturers - Specialty & Generic Glil Yam, TA 4690500 imcannabis.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$54.7M+28.1% 5y CAGRd
20112025
Net income
-$-11.32M
20112025
Free cash flow
$4.7M
20112025
Total equity
-$-3.62M
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$54.7M$54M$48.8M$54.3M$34.1M
Operating income-$-11.59M-$-10.23M-$-12.79M-$-30.79M-$-23.04M
Net income-$-11.32M-$-10.59M-$-9.5M-$-188.89M-$-17.76M
EPSd-$-2.67M-$-4.51M-$-4.44M-$-164.25M-$-3M
Operating cash flow$4.72M-$-1.08M-$-8.07M-$-12.64M-$-34.37M
Capital expenditure-$-10K-$-160K-$-580K-$-1.56M-$-4.59M
Free cash flow$4.7M-$-1.23M-$-8.66M-$-14.2M-$-38.97M
Total assets$31.7M$39.2M$48.8M$60.7M$287.4M
Total debt$16.3M$18M$13.8M$11.5M$29.3M
Net debt$13.5M$17.2M$12M$9.09M$15.4M
Total equity-$-3.62M$3.15M$13.7M$23.8M$204.9M
Cash and short-term investments$2.73M$860K$1.81M$2.45M$13.9M
Income statement
20252024202320222021
Revenue$54.7M$54M$48.8M$54.3M$34.1M
Cost of revenue$45.1M$45.6M$39M$45.2M$27.7M
Gross profit$9.69M$8.45M$9.85M$9.16M$6.33M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$12.9M$13.3M$19M$28.9M$28.1M
Other expenses$8.34M$5.41M$3.61M$11.1M$1.27M
Operating expenses$21.3M$18.7M$22.6M$40M$29.4M
Cost and expenses$66.3M$64.3M$61.6M$85.1M$57.1M
Interest income$0.00$1.91M$7.01M$6.7M$23.5M
Interest expense$2.76M$4.47M$3.67M$1.97M$670K
Depreciation and amortization$1.96M$2.18M$3M$7.33M$5.73M
Ebitda-$-6.95M-$-6.14M-$-2.79M-$-16.76M$6.24M
Operating income-$-11.59M-$-10.23M-$-12.79M-$-30.79M-$-23.04M
Total other income/expenses, net-$-70K-$-2.56M$3.33M$4.73M$22.9M
Income before tax-$-11.66M-$-12.79M-$-9.46M-$-26.06M-$-160K
Income tax expense$90K-$-1.02M$770K-$-1.14M$500K
Net income-$-11.32M-$-10.59M-$-9.5M-$-188.89M-$-17.76M
Weighted average shares outstanding$4.24M$2.35M$2.14M$2.46M$3.11M
Weighted average diluted shares outstanding$4.24M$2.35M$2.14M$1.15M$5.92M
Balance sheet
20252024202320222021
Cash and short-term investments$2.73M$860K$1.81M$2.45M$13.9M
Net receivables$13M$16.7M$11.3M$10.5M$31.2M
Inventory$4.27M$3.21M$9.98M$16.6M$31.1M
Total current assets$22.7M$23.4M$24.3M$32.7M$81.2M
Property, plant and equipment, net$4.11M$4.18M$6.37M$7.15M$48.4M
Goodwill and intangible assets$3.11M$10M$15.9M$17.7M$152.2M
Long-term investments$1.78M$1.63M$2.29M$2.41M$2.43M
Total non-current assets$8.99M$15.8M$24.6M$28M$203.1M
Total assets$31.7M$39.2M$48.8M$60.7M$287.4M
Accounts payable$12.1M$11.2M$9.22M$15.3M$14M
Short-term debt$15.3M$17.4M$12.6M$10.1M$11.1M
Deferred revenue$210K$490K$790K$30K$140K
Total current liabilities$34M$34.9M$32.9M$33.8M$51.2M
Long-term debt$990K$640K$1.21M$1.47M$18.2M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.34M$1.12M$2.31M$3.06M$31.2M
Capital lease obligations$380K$430K$1.27M$1.89M$19.4M
Total liabilities$35.4M$36M$35.1M$36.9M$82.4M
Common stock$270.5M$265M$253.9M$245.8M$237.7M
Retained earnings-$-270.21M-$-258.94M-$-249.15M-$-238.91M-$-50.74M
Accumulated other comprehensive income (loss)-$-3.81M-$-1.26M$100K$16.5M$2.61M
Total equity-$-3.62M$3.15M$13.7M$23.8M$204.9M
Total investments$1.78M$1.63M$2.29M$2.41M$2.43M
Total debt$16.3M$18M$13.8M$11.5M$29.3M
Net debt$13.5M$17.2M$12M$9.09M$15.4M
Cash flow statement
20252024202320222021
Net income-$-11.75M-$-11.77M-$-10.23M-$-191.3M-$-18.52M
Depreciation and amortization$1.96M$2.18M$3M$7.33M$5.73M
Stock-based compensation$10K$370K$230K$3.77M$7.47M
Change in working capital$7.84M$2.48M$1.4M$34.5M-$-10.82M
Accounts receivable$4.06M-$-6.29M$2.32M$6.06M-$-6.6M
Inventory-$-720K$6.26M$4.77M$1.45M-$-13.29M
Accounts payable$1.74M$7.84M-$-6.1M$11.3M$5.57M
Net cash provided by operating activities$4.72M-$-1.08M-$-8.07M-$-12.64M-$-34.37M
Investments in property, plant and equipment-$-10K-$-160K-$-580K-$-1.56M-$-4.59M
Acquisitions, net$0.00-$-350K$0.00-$-410K-$-12.55M
Net cash used for investing activities-$-530K-$-470K-$-1.18M-$-1.41M-$-9.01M
Common stock issued$5.07M$940K$1.69M$3.76M$28.1M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$1.15M$3.83M$9.42M$4.76M$48.7M
Net change in cash$1.86M-$-950K-$-640K-$-11.45M$5.02M
Cash at end of period$2.73M$860K$1.81M$2.45M$13.9M
Operating cash flow$4.72M-$-1.08M-$-8.07M-$-12.64M-$-34.37M
Capital expenditure-$-10K-$-160K-$-580K-$-1.56M-$-4.59M
Free cash flow$4.7M-$-1.23M-$-8.66M-$-14.2M-$-38.97M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About IM Cannabis Corp.

        IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

        CEO
        Oren Shuster
        Employees
        44
        Beta
        2.04

        Explore

        Frequently asked questions

        What is the intrinsic value of IM Cannabis Corp. (IMCC)?

        InvestorsCraft does not currently publish an intrinsic value for IMCC. How the IC value is calculated.

        Is IMCC undervalued?

        InvestorsCraft does not publish an undervaluation signal for IMCC at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.